News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,496 Results
Type
Article (7990)
Company Profile (11)
Press Release (184495)
Section
Business (75891)
Career Advice (448)
Deals (10978)
Drug Delivery (15)
Drug Development (21969)
Employer Resources (52)
FDA (4155)
Job Trends (4047)
News (112326)
Policy (8131)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (2)
2025 Lone Star Bio Digital (1)
Academia (675)
Adcomms (11)
Allergies (23)
Alliances (13042)
ALS (13)
Alzheimer's disease (391)
Antibody-drug conjugate (ADC) (22)
Approvals (4186)
Artificial intelligence (59)
Autoimmune disease (1)
Automation (2)
Bankruptcy (69)
Best Places to Work (3428)
BIOSECURE Act (3)
Biosimilars (15)
Biotechnology (7)
Bladder cancer (13)
Brain cancer (6)
Breast cancer (44)
Cancer (499)
Cardiovascular disease (24)
Career advice (376)
Career pathing (10)
CAR-T (22)
Cell therapy (80)
Cervical cancer (3)
Clinical research (18322)
Collaboration (193)
Compensation (19)
Complete response letters (2)
COVID-19 (501)
CRISPR (10)
C-suite (63)
Cystic fibrosis (18)
Data (481)
Decentralized trials (1)
Denatured (3)
Depression (4)
Diabetes (64)
Diagnostics (1972)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (25)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (7)
Earnings (42176)
Editorial (2)
Employer branding (8)
Employer resources (47)
Events (26922)
Executive appointments (172)
FDA (4391)
Featured Employer (4)
Frontotemporal dementia (3)
Funding (109)
Gene editing (21)
Generative AI (7)
Gene therapy (54)
GLP-1 (109)
Government (951)
Grass and pollen (1)
Guidances (22)
Healthcare (5017)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (10)
Indications (10)
Infectious disease (531)
Inflammatory bowel disease (29)
Influenza (11)
Intellectual property (16)
Interviews (65)
IPO (5589)
IRA (2)
Job creations (799)
Job search strategy (348)
Kidney cancer (7)
Labor market (2)
Layoffs (71)
Leadership (3)
Legal (1491)
Liver cancer (19)
Lung cancer (94)
Lymphoma (35)
Machine learning (1)
Management (19)
Manufacturing (54)
MASH (1)
Medical device (4151)
Medtech (4151)
Mergers & acquisitions (5464)
Metabolic disorders (108)
Multiple sclerosis (17)
Neurodegenerative disease (12)
Neuropsychiatric disorders (2)
Neuroscience (481)
NextGen: Class of 2025 (1596)
Non-profit (1204)
Northern California (482)
Now hiring (2)
Obesity (53)
Opinion (36)
Ovarian cancer (20)
Pain (9)
Pancreatic cancer (15)
Parkinson's disease (35)
Patents (30)
Patient recruitment (21)
Peanut (16)
People (18605)
Pharmaceutical (8)
Phase I (4857)
Phase II (7729)
Phase III (6953)
Pipeline (306)
Podcasts (6)
Policy (9)
Postmarket research (793)
Preclinical (1977)
Press Release (12)
Prostate cancer (23)
Psychedelics (2)
Radiopharmaceuticals (83)
Rare diseases (64)
Real estate (1493)
Recruiting (19)
Regulatory (6151)
Reports (8)
Research institute (639)
Resumes & cover letters (63)
RSV (9)
Schizophrenia (12)
Series A (23)
Series B (14)
Service/supplier (1)
Sickle cell disease (11)
Southern California (491)
Sponsored (6)
Startups (761)
Stomach cancer (4)
Supply chain (10)
The Weekly (3)
United States (4609)
Vaccines (119)
Venture capitalists (5)
Webinars (6)
Weight loss (23)
Women's health (4)
Worklife (5)
Date
Today (32)
Last 7 days (198)
Last 30 days (722)
Last 365 days (8999)
2025 (1322)
2024 (9413)
2023 (11398)
2022 (15121)
2021 (16430)
2020 (15728)
2019 (13601)
2018 (10418)
2017 (10562)
2016 (9578)
2015 (11834)
2014 (8383)
2013 (6494)
2012 (7139)
2011 (7618)
2010 (6697)
Location
Africa (249)
Alabama (6)
Arizona (29)
Arkansas (1)
Asia (14254)
Australia (2596)
California (1145)
Canada (480)
China (158)
Colorado (55)
Connecticut (34)
Delaware (35)
Europe (31039)
Florida (199)
Georgia (39)
Idaho (23)
Illinois (108)
India (5)
Indiana (79)
Japan (73)
Kansas (22)
Kentucky (5)
Louisiana (4)
Maine (37)
Maryland (168)
Massachusetts (798)
Michigan (65)
Minnesota (90)
Missouri (15)
Montana (12)
Nebraska (6)
Nevada (18)
New Hampshire (23)
New Jersey (441)
New Mexico (4)
New York (324)
North Carolina (254)
North Dakota (1)
Northern California (482)
Ohio (43)
Oklahoma (3)
Oregon (3)
Pennsylvania (280)
Puerto Rico (3)
Rhode Island (5)
South America (433)
South Carolina (5)
Southern California (491)
Tennessee (17)
Texas (136)
Utah (41)
Virginia (13)
Washington D.C. (10)
Washington State (122)
West Virginia (1)
Wisconsin (12)
192,496 Results for "biomatrix international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
BioMatrix Specialty Infusion Pharmacy Acquired by Frazier Healthcare Partners
BioMatrix Specialty Infusion Pharmacy (“BioMatrix” or “The Company”) announced today the sale of the majority interests of the company from Acon Investments & Triton Pacific Healthcare to Frazier Healthcare Partners (“Frazier”).
June 25, 2024
·
3 min read
Business
Ted Kramm Appointed To BioMatrix Specialty Pharmacy Board Of Directors
BioMatrix Specialty Pharmacy is pleased to announce the appointment of Ted Kramm to the Board of Directors.
January 8, 2024
·
1 min read
BioCapital
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
Elutia Inc. (Nasdaq: ELUT) today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its next-generation drug-eluting biomatrix product, CanGarooRM®.
December 18, 2023
·
6 min read
BioMidwest
BioMatrix Specialty Pharmacy Recognized by the National Association for Business Resources with a 2023 Best and Brightest Company to Work For Award
BioMatrix Specialty Pharmacy announced the organization has been recognized with a fifth consecutive “Best and Brightest Companies to Work For in the Nation” award.
September 21, 2023
·
3 min read
Business
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
Elutia Inc., a company pioneering drug-eluting biomatrix products, announced that it will release its first quarter 2024 financial results after market close on Thursday, May 9, 2024.
May 2, 2024
·
1 min read
BioCapital
Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting BioEnvelope, EluPro® (referred to as CanGaroo®RM during development), has received clearance from the U.S. Food and Drug Administration (FDA).
June 17, 2024
·
7 min read
Business
Lineage Broadens Collaboration With Advanced BioMatrix for HyStem® Cell Drug Delivery Technology
Lineage Broadens Collaboration With Advanced BioMatrix for HyStem ® Cell Drug Delivery Technology.
June 2, 2022
·
6 min read
Press Releases
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women’s Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)
February 27, 2025
·
4 min read
Biotech Bay
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion.
June 21, 2024
·
3 min read
Business
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
Elutia Inc., a company pioneering drug-eluting biomatrix products, announced that it will release its fourth quarter and full year 2023 financial results after market close on Thursday, March 7, 2024.
February 22, 2024
·
1 min read
1 of 19,250
Next
